Cardiology

  • In reply: Infective endocarditis: Don’t forget the ICE
    Nkemdilim Mgbojikwe, MD, Steven R. Jones, MD, Thorsten M. Leucker, MD, PhD and Daniel J. Brotman, MD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 192; DOI: https://doi.org/10.3949/ccjm.87c.04002

    Echocardiography relies on finding an anatomic abnormality, whereas 18FDG-PET is a functional examination.

  • ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
    Cara Reiter-Brennan, Albert D. Osei, MD, MPH, S. M. Iftekhar Uddin, MBBS, MSPH, Olusola A. Orimoloye, MD, MPH, Olufunmilayo H. Obisesan, MD, MPH, Mohammadhassan Mirbolouk, MD, Michael J. Blaha, MD, MPH and Omar Dzaye, MD, PhD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 231-239; DOI: https://doi.org/10.3949/ccjm.87a.19078

    Risk assessment, drugs, patient subgroups, value of therapy, personalized plans, and shared decision-making.

  • Mitral valve prolapse and sudden cardiac death: A perspective on risk-stratification
    Aaron A. H. Smith, MD and Omer J. Iqbal, MD, FHRS
    Cleveland Clinic Journal of Medicine March 2020, 87 (3) 136-138; DOI: https://doi.org/10.3949/ccjm.87a.19096

    Mitral valve prolapse is common, but sudden cardiac death is rare. How can we stratify risk?

  • Pharmacogenomics: An evolving clinical tool for precision medicine
    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99; DOI: https://doi.org/10.3949/ccjm.87a.19073

    More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Are we all clear? Unintended shocks to caregivers during cardiopulmonary resuscitation
    David R. Lowery, MD, FASA, Maj, MC, USA, Daniel Cantillon, MD, FACC, FHRS and Donn Marciniak, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 16-18; DOI: https://doi.org/10.3949/ccjm.87a.19022

    Defibrillators are designed to affect electrical activity in the patient’s heart. Caregivers, be careful!

  • Sickle cell disease: A primary care update
    Grace Onimoe, MD and Seth Rotz, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 19-27; DOI: https://doi.org/10.3949/ccjm.87a.18051

    Survival has improved, but patients still face multiorgan damage, chronic anemia, and debilitating pain crises.

  • Cardio-obstetrics: Recognizing and managing cardiovascular complications of pregnancy
    Cardio-obstetrics: Recognizing and managing cardiovascular complications of pregnancy
    Kayle S. Shapero, MD, PhD, Nihar R. Desai, MD, MPH, Robert W. Elder, MD, Heather S. Lipkind, MD, Josephine C. Chou, MD, MS and Erica S. Spatz, MD, MHS
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 43-52; DOI: https://doi.org/10.3949/ccjm.87a.18137

    Pregnancy can exacerbate known cardiovascular disorders and unmask previously unrecognized problems.

  • Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Robert Fakheri, MD, Sripal Bangalore, MD and Franz Messerli, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9; DOI: https://doi.org/10.3949/ccjm.87c.01001
  • In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Sunil Bhandari, MBChB, FRCP, PhD, M Clin Edu, FHEA, Tasnim Momoniat, MBChB, MRCP (UK) and Duha Ilyas, MBBS, MRCP (UK)
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.87c.01002
  • Should I evaluate my patient with atrial fibrillation for sleep apnea?
    Mirna B. Ayache, MD, MPH, Reena Mehra, MD, MS, FCCP, FAASM and Kenneth A. Mayuga, MD, FACC, FHRS
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 709-712; DOI: https://doi.org/10.3949/ccjm.86a.19033

    Yes. The prevalence of sleep apnea is high in patients with atrial fibrillation, and vice versa.

Pages